Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Cosmos caudatus extract is as effective as finasteride for treating benign prostatic hyperplasia without its side effects.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

1α,25-dihydroxyvitamin D3 directly affects cartilage growth and development.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Biosimilars lower costs but don't significantly improve access.

CRH promotes fat production in skin cells, affecting conditions like acne.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

A neurosteroid can reduce caffeine-induced anxiety in rats.

Baricitinib is the most effective treatment for alopecia areata.

Certain substances can decrease or increase exploratory behavior in rodents.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

IGFBP5 may be a potential target for Parkinson's treatment by reducing neuron death.

Ritlecitinib is safe and may effectively treat alopecia areata.

VR1 signaling can inhibit hair growth by affecting cell processes and increasing hair growth inhibitors.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Canakinumab's effect on COVID-19 outcomes is unclear.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Three drugs change mice's alcohol drinking patterns by affecting GABAA receptors.

Vitamin D receptor knockout mice have significant motor impairments but no cognitive deficits.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.